Company
Avacta Group PLC
LON:AVCT
At Avacta we have developed Affimer technology, an engineered alternative to antibodies. Based on a small protein, Affimer technology can be quickly developed to bind with high specificity and affinity to a wide range of targets. Affimer proteins can be developed as therapeutic molecules and can be used in a wide range of other life sciences applications in research and diagnostics.
207 stories · page 1 of 3
Avacta soars on another successful clinical study
Avacta shares jumped as the firm hailed the success of its chemotherapy drug
Avacta Group receives orphan drug designation from US FDA
The US FDA designation qualifies the drug developer to receive certain incentives, including seven years of market exclusivity upon drug approval
Avacta moves onto next phase of cancer study
AVA6000 is a novel form of anti-cancer medication doxorubicin that has been modified by Avacta's delivery platform for improved safety
Avacta JV raises funds for stem cell projects
Proceeds from the fundraise will support Investigational New Drug (IND) enabling studies that will underpin a regulatory filing to bring its lead programme to market
Avacta announces second dose escalation in cancer study after positive safety review
CEO Alastair Smith said the treatments have the "potential to deliver safer and affordable oncology drugs that could significantly improve cancer patients' lives"
Archive
Serinus Energy moves closer to start of drilling in Romania
A look at the major movers on the London market on Wednesday
Avacta JV AffyXell agrees drug development collaboration
The deal should enhance the translation of AffyXell's programmes into human trials and accelerate drug development
Avacta full-year results push shares higher
In London, Avacta shares were up 6.7% trading at 68.3p.
Archive
Caspian Sunrise climbs on positive production and financial update
A look at the major movers on the London market on Wednesday
Archive
Arcontech slumps as customers reduce spend
A look at some of the major movers in London on Monday
Avacta starts shipment of new rapid COVID-19 test
The assay has been shown by independent clinical evaluation to be 100% sensitive for patient samples with a high viral load
Archive
Record on the right track with UBS partnership
A look at the major movers on the London market on Tuesday
A year of COVID-19: the healthcare industry
It’s been a year since the UK had to revolutionise its way of life to cope with the pandemic, while the healthcare sector has been at the forefront of it all
Avacta notes press speculation on UK Government take-up of rapid COVID-19 test
It is understood that the Avacta rapid kits could play a key part in the so-called ‘Operation Moonshot’ to reopen public places such as theatres, clubs and cinemas
Avacta, Clipper, Eurasia Mining and Persimmon in broker's new 'climate portfolio'
The initial portfolio is made up of 20 stocks, ranging from three from the FTSE 100 to more than half a dozen from AIM
Pharma learns many lessons from COVID-19 shockwave
2020 has been a transformative year for the industry
Avacta to launch affimer-based laboratory test for COVID-19
The assay uses enzyme-linked immunosorbent assays (ELISAs) and Avacta's engineered proteins Affimers
Avacta Group: Liverpool School of Tropical Medicine to validate rapid coronavirus test
Scientists will evaluate the performance of a diagnostic test using real patient samples
Avacta tackles the pandemic on all fronts with its Affimer technology
The biotech is using its engineered proteins to develop diagnostics and treatment for Covid-19
Coronavirus: UK to trial saliva tests for asymptomatic cases, Evan Bioscences’ candidate enters Cambridge trial, R factor rises in Germany…
A look at Monday's major developments regarding coronavirus spread, testing and treatment
Archive
Proactive news snapshot: Avacta, Itaconix, SDX Energy, Premier African Minerals …
A glance at some of the day's highlights from the Proactive Investors newswire
Avacta "highly encouraged" by early results from dual threat cancer drug
The new technology outperformed Bavencio, a PD-L1 antibody inhibitor for lung cancer sold by Merck and Pfizer
Archive
Small Cap Wrap - Gear4music, Avacta Group, ITM Power and more...
Dish of the day No Joiners Today Off the menu No Leavers Today What’s cooking in the IPO kitchen?
Archive
Proactive news snapshot: Avacta Group, Diversified Gas & Oil, Summit Therapeutics PLC, Arix Bioscience …
A glance at some of the day's highlights from the Proactive Investors newswire
Avacta's revenues and cash ahead of expectation as it prepares to take its first drug candidate into the clinic
The company is the developer of antibody-like proteins called Affimers
Archive
CLS Holdings dips over acquisition, sale
A look at the day's major movers in the London Stock Exchange
Avacta creates cell therapy JV with Korea's Daewoong Pharmaceutical
The new joint venture with Daewoong Pharmaceutical will target development of a new class of stem cells that are primed to produce Affimer proteins against several undisclosed targets
Avacta says expanded LG Chem collaboration could trigger further "substantial" payments
The company is a specialist in developing Affimers, which are engineered proteins that help drugs more effectively target diseases such as cancer
Avacta raises £9mln as its moves towards first clinical trial
Seven evaluations are ongoing with possible partners, which includes four out of the top ten global diagnostics companies.
Archive
XP Power sparks as orders rise despite semiconductor slowdown
A look at some of the major risers and fallers in London on Thursday
Avacta inks collaboration with ADC Therapeutics SA
The two firms will join forces to develop drug conjugates based on Avacta’s Affimer rather than standard antibodies
Archive
Proactive news snapshot: Europa Oil & Gas, Integumen, Victoria Oil & Gas...
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
Proactive news snapshot: Shanta Gold, Ceres Power, Anglo Asian Mining …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
BCA Marketplace board minded to recommend 243p a share offer, if it is made
A look at the day's major movers, including Premier Technical, Evraz, Gunsynd, Dixons Carphone, Serabi Gold and EVR
Avacta teams up with Selexis to develop Chinese hamster ovary cell line
On the tie-up with Selexis, Avacta chief executive Alastair Smith said the company's new partner provided “the technology and know-how” to develop the required cell lines for the planned first-in-human study
Investments and investor services
FTSE 100 closes higher as global markets buoyed by Fed's hint on rates
Carnival and Evra were the two big fallers among Footsie constituents
Archive
Ted Baker tumbles to seven-year low as HSBC slashes target
A look at the day's major movers, including Ted Baker, IAG, easyJet, Bagir, Blue Prism, EVR, Blackbird, Nu-Oil & Gas, Anglo Asian Mining and Petrel Resources
Archive
Proactive news snapshot: Nu-Oil and Gas, Futura Medical, Anglo Asian Mining …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
FTSE 100 slips at close as investors brace for US Fed decision
All eyes will be on the statement from Fed rate setters later, especially due to the pressure to lower rates from President Trump
Archive
Scapa boss not scarpering after all
A look at the day's major movers, including Helical, Ocado, Thomas Cook, Scapa, Dods Group, Rockfire Resources and Avesoro Resources
Archive
Proactive news snapshot: AfriTin Mining, Union Jack Oil, Eurasia Mining …
A glance at some of the day's highlights from the Proactive Investors newswire
Avacta selects drug candidate for phase I trial
The important milestone puts the company on track to file a new drug/clinical application by the end of 2020 as planned
Investments and investor services
FTSE 100 closes higher as trade tensions ease
The UK's index of leading shares finished the first day of the trading week around 46 points higher at 7,378
Archive
Proactive news snapshot: Argo Blockchain, Sareum Holdings, WideCells Group …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
EQTEC gives ground as it draws on its loan facility
A look at the day's major movers, including Carclo, Sareum, Karelian, Kier, Fulcrum, Microsaic, Dignity and Scapa
Avacta plans for exciting cancer immunotherapy
The group's technology releases chemo directly inside a tumour without exposing the whole body to toxins
Investments and investor services
FTSE 100 closes higher despite continued trade worries
The UK's blue-chip benchmark added over 23 points to close at 7,184
Avacta makes progress with development of affimer candidates
Avacta is using affimers to develop its own cancer therapy, but it also licenses the technology to other companies, including major pharma group ModernaTX and LG Chem Life Sciences
Investments and investor services
Vp hit by Competition and Markets Authority decision
A look at the day's major movers, including The Mission Marketing Group, Sirius Minerals, 7digital, Nuformix, Defenx and Shearwater
Archive
Proactive news snapshot: ReNeuron, AFC Energy, Collagen Solutions, AppScatter …
A glance at some of the day's highlights from the Proactive Investors newswire
Avacta well-cashed and on track to begin clinical trial of first Affimer therapeutic next year
The first Affimer-based therapeutic is PD-L1 is a potential cancer treatment that helps the immune system to identify and attack cancer cells
Investments and investor services
FTSE 100 closes in the red as Brexit and trade war fears continue to hit sentiments
The International Monetary Fund issued a warning, saying a "no-deal" Brexit would send the British economy into severe shock
Archive
Sumo no heavyweight but finals should show good development, yet unlikely to divert from Brexit
The Day Ahead will continue to be dominated by the Brexit saga, with the corporate news diary limited to small cap firms, including City Pubs Group, Destiny Pharma
Archive
Retailers Tesco and ASOS to provide the main corporate excitement in coming week
Also on the retail front, WH Smith and Dunelm will issue updates as well in the Week Ahead, while on the macro front an ECB rate decision and US FOMC meeting minutes are also due
Archive
Proactive news snapshot: Diversified Gas & Oil, Seeing Machines, PCF Group …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
Proactive news snapshot: Tissue Regenix, Avacta Group, Mkango Resources …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
Tri-Star shines bright as it awaits first antimony ingot from Oman
Some of the main news-driven risers and fallers in London on Monday…
Avacta says partner Moderna takes collaboration to next level
The US-listed group has triggered an exclusivity option. Chief executive Dr Alastair Smith said: "This is further strong validation of the potential of the Affimer drug platform to generate differentiated therapeutic molecules for developme
Investments and investor services
FTSE 100 closes a shade higher as Wall Street chugs upward
The UK's premier share index added nearly 14 points to close at 7,034
Archive
Proactive news snapshot: Kavango Resources, Futura Medical, Kromek …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
SimplyBiz full of zest as Taylor Wimpey joins the customer list
A look at the day's major movers, including Sensyne Health, Reabold Resources, Maintel, Nu-Oil, Altona Energy, Flybe and PCI-PAL
Investments and investor services
FTSE 100 closes lower as trade worries dent global equities; Ocado top Footsie gainer
A deceptively dull start by the Footsie gradually turned into something a bit more dramatic
Avacta Group trading in line in "year of very significant progress"
An update on the collaboration with Moderna is planned for the first half of this year
Archive
Proactive news snapshot: Redx Pharma, Ariana Resources, Avacta Group …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Nakama stumbles in final quarter of 2018
A look at the day's major movers, including Panthera Resources, Filtronic, Keystone Law, MOD Resources and Modern Water
Investments and investor services
FTSE 100 nudges lower at close as China growth worries hit stocks
The UK's blue-chip index finished down nearly seven points at 6,96, while FTSE 250 was also lower
Investments and investor services
Brexit a factor in easyJet update, while US/China trade wars could be a drag for Burberry
The Week Ahead will also bring trading updates from the likes of Vodafone, Anglo American, William Hill, Dixons Carphone, and WH Smith, plus the latest UK jobs and wages data
Archive
Proactive news snapshot: Kodal Minerals, LoopUp Group, Providence Resources …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
Proactive news snapshot: ECR Minerals, Highlands Natural Resources, Victoria Oil & Gas …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
FTSE 100 changes direction to close higher on first day of trading in 2019; Wall Street shares up
The FTSE 100 recovered in afternoon trading and closed up six points at 6,734
Archive
Proactive news snapshot: Summit Therapeutics, Plexus Holdings, Concepta...
A glance at some of the day's highlights from the Proactive Investors newswire
Avacta Group event to focus on immuno-oncology advances and role of its technology in the emerging field of science
Dr Josep Tabernero, President of the European Society for Medical Oncology and Head of the Val d'Hebron Institute of Oncology, Barcelona, will give the plenary presentation
Archive
FTSE 100 closes lower as US sinks with Santa rally looking a vague memory
At the close, the FTSE 100 was down 71.93 points, or 1.1% at 6,773.24, just above the session low of 6,761.37 and well below the early high of 6,845.17.
Franco Manca and Real Greek owner Fulham Shore rallies after solid first-half results
Some of the main news-driven risers and fallers in London on Wednesday...
Archive
Proactive news snapshot: Taptica International, i3 Energy, Seeing Machines …
A glance at some of the day's highlights from the Proactive Investors newswire
Avacta appoints industry heavyweight as chief medical officer
Dr Jose Saro is joining the business from the Roche Innovation Center
FTSE 100 closes higher on speculation Prime Minister May will survive Brexit-related no-confidence vote
The benchmark index also gets a boost from optimism over US-China trade talks
Archive
Proactive news snapshot: Avacta, ValiRx, Minds + Machines Group …
A glance at some of the day's highlights from the Proactive Investors newswire
Pressure Technologies steps on the gas after agreeing to sell its alternative energy division
A look at the day's major movers, including Local Shopping REIT, Just Group, Photo-Me, Lb-Shell, Avacta and ValiRx
Avacta soars after signing partnership deal with Korea's LG Group
The Affimer technology is Avacta's proprietary alternative to antibodies with wide applications in the life sciences for drug development, diagnostics and research tools
Investments and investor services
FTSE 100 closes lower as UK Prime Minister pulls plug on key Brexit vote
The UK premier index finished down around 56 points at 6,721 on Monday
Avacta’s Affimer tech gains traction as it clinches deal with “very high quality partner”
The deal with New England Biolabs, signed in October, is expected to secure six-figure royalty sums as soon as next year
Archive
Proactive news snapshot: Sirius Minerals, MaxCyte, Arix Bioscience...
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Two Shields and Bushveld wave the flag for African mineral assets
A look at the day's winners and sinners, including Dignity, Online Blockchain, Restaurant Group, TomCo Energy, Johnston Press, GYG, Anglo African Agriculture and Carr's Group